|
Press Releases |
|
 |
|
Friday, June 20, 2025 |
|
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health |
Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single largest infectious cause of death in children worldwide. more info >> |
|
Tuesday, March 25, 2025 |
|
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong |
CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant revenue growth in 2024, driven by continuous R&D innovation and strong commercial capabilities. more info >> |
|
Wednesday, October 9, 2024 |
|
CanSino Receives Another Strong Boost |
CanSino Biologics Inc. ("CanSinoBIO" or "the Company") has announced a milestone in its fight against polio. more info >> |
|
Thursday, August 29, 2024 |
|
CanSinoBIO Reports Outstanding H1 2024 Performance |
CanSino Biologics Inc. (CanSinoBIO) today disclosed its performance report for the first half of 2024, with revenue reaching 303 million yuan, while losses were substantially reduced. more info >> |
|
Friday, April 26, 2024 |
|
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine |
On April 20, the 2024 National Vaccines and Health Conference organized by the Chinese Preventive Medicine Association (CPMA) and the Chinese Center for Disease Control and Prevention (China CDC) took place in the Xiong'an New Area of Hebei Province. more info >> |
|
Wednesday, March 27, 2024 |
|
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough |
In 2023, CanSinoBIO's meningococcal conjugate vaccine achieved revenue approximately RMB561.72 million, representing a year-on-year increase of approximately 266.39% compared to last year. The growth trend is evident. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
TransNusa Focuses on Organic Growth to Strengthen Network Connectivity in China
Aug 11, 2025 23:55 HKT/SGT
|
|
|
Campaign to promote Hong Kong's advantages in professional services in Vietnam
Aug 11, 2025 22:46 HKT/SGT
|
|
|
Shoucheng-Backed Data Center REITs Surge on Market Debut
Aug 11, 2025 22:43 HKT/SGT
|
|
|
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore
Aug 11, 2025 22:42 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 11, 2025 22:39 HKT/SGT
|
|
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 11, 2025 22:34 HKT/SGT
|
|
|
Singapore's Digital Finance Model in Focus at the BFSI IT Summit - Singapore 2025
Aug 11, 2025 18:26 HKT/SGT
|
|
|
WRC 2025: Shoucheng Showcases Full Robotics Value Chain
Aug 11, 2025 16:27 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 11, 2025 10:41 HKT/SGT
|
|
|
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million
Aug 11, 2025 08:15 HKT/SGT
|
|
|
Saudi Electricity Company Reports 22% Net Profit Growth in Q2 2025
Aug 11, 2025 06:00 HKT/SGT
|
|
|
Intervision'25 International Music Contest to Take Place: Michael Jackson's Descendant Expected to Participate
Aug 10, 2025 21:00 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 8, 2025 15:19 HKT/SGT
|
|
|
Chinese Culinary Culture Training Programme: 30 Hong Kong Students Embarked on a Study Tour in Chaoshan
Aug 8, 2025 14:40 HKT/SGT
|
|
|
DAESHIN MC Targets Singapore Market with Smart Cleaning Solutions at 'BEX ASIA 2025'
Aug 8, 2025 10:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|